Clovis Oncology, Inc. (CLVS) has seen some recent volatility in the marketplace and its shares were last quoted at $6.47 yesterday. Investors are starting to take notice of CLVS as the shares traded as high as $6.48 and as low as $6.25 in the previous market session.
Clovis Oncology, Inc. (CLVS) average trading volume is 6.16M. However, in the previous market session Clovis Oncology, Inc. (CLVS) traded 2,745,072 shares. The First support level on CLVS is $3.76 and the First upside resistance level on CLVS is $11.00. CLVS 50-day moving average is $6.58 and CLVS two hundred day moving average is $7.39.
Clovis Oncology, Inc. (CLVS) most current performance has been shown by the recent movement in CLVS shares. CLVS has performed -1.75% over the past 30 days, CLVS has performed -19.89% over the past quarter and CLVS has shown -31.37% over the past 12 months. Clovis Oncology, Inc. (CLVS) has a 52 week range of $2.93 to $17.37. Clovis Oncology, Inc. (CLVS) is trading 120.65% from its 52 week low and -62.78% from its 52 week high. Clovis Oncology, Inc. (CLVS) is showing a 46.83% short float showing the sum short in the float.
CLVS has 71.66M shares outstanding and 69.72M shares in the float. Clovis Oncology, Inc. (CLVS) at this time has a market cap of $602.73M and income of -413.30M. The EPS next quarter for CLVS is -1.04 and projected EPS next year is 42.40%. The market cap of Clovis Oncology, Inc. (CLVS) at $602.73M represents how many Investors own shares of CLVS and is calculated off the last price ($6.47) of CLVS and the sum of shares outstanding (71.66M) with Clovis Oncology, Inc. (CLVS).
Clovis Oncology, Inc. (CLVS) has aggregate cash (mrq) of 228.36M, aggregate cash per share (mrq) of 2.97, aggregate debt of CLVS remains at 610.45M. Clovis Oncology, Inc. (CLVS) operating cash flow (ttm) is -307.66M, CLVS leveraged free cash flow (ttm) is -152.2M.
CLVS is trading 2.20% above (bullish) its SMA20, -3.63% below (bearish) its SMA50 and -16.44% below (bearish) its SMA200.